Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2024-01-05 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
北京市康达律师事务所关于拓新药业集团股份有限公司2024年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2024 first extraordinary general meeting (临时股东大会) of the company. It details the legality and validity of the meeting's call, attendance, and voting process, but does not contain financial statements or management discussion. It is not the actual meeting materials or voting results announcement but a legal opinion on the meeting's procedural compliance. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to shareholder meeting voting results and their legality. The document length is 4518 characters, which is substantial and contains detailed legal opinion rather than a brief announcement or a report publication notice. Therefore, the best classification is DVA with high confidence.
2024-01-05 Chinese
关于变更公司董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the company's board of directors, specifically the resignation of one director and the election of another. It includes details about the departing director, the newly elected director, and their qualifications. There is no financial data, report publication, or other types of filings such as earnings or annual reports. The content clearly fits the category of Board/Management Information, which covers announcements of changes in the company's board or senior management.
2024-01-05 Chinese
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2024 first extraordinary general meeting of shareholders of the company 拓新药业集团股份有限公司. It details the meeting date, attendance, voting results on board director resignation and election, and includes legal opinions confirming the validity of the meeting and voting process. The document does not contain financial statements or detailed financial analysis but focuses on the shareholder meeting outcomes and voting results. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA). The document length is short (1701 characters), and it is not merely announcing the availability of a report but providing the actual voting results. Therefore, the correct classification is DVA with high confidence.
2024-01-05 Chinese
关于变更公司监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the company's supervisory board (监事), specifically the resignation of one supervisor and the election of another. It includes details about the individuals involved and references to relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content fits the category of Board/Management Information, as it concerns changes in company governance personnel.
2023-12-25 Chinese
北京市康达律师事务所关于拓新药业集团股份有限公司2023年第四次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2023 fourth extraordinary general meeting (临时股东大会) of the company 拓新药业集团股份有限公司. It details the legality and validity of the meeting's call, attendance, and voting process, including the approval of specific resolutions such as changes in registered capital, amendments to company bylaws, and election of supervisors. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholder meeting and its voting results. This type of document is a legal opinion related to shareholder meeting procedures and voting outcomes, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5115 characters, which is sufficient for a detailed legal opinion letter rather than a brief announcement. Therefore, the best classification is DVA.
2023-12-25 Chinese
2023年第四次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions passed at the 2023 fourth extraordinary general meeting of shareholders of the company. It details the meeting date, attendance, voting results on various proposals including changes in registered capital, amendments to company articles, and election of supervisors. It also includes legal opinions confirming the validity of the meeting and voting process. The document is not a full annual or interim report, nor a financial statement or earnings release. It is not a proxy solicitation or a remuneration report. The content is focused on the official voting results and meeting resolutions. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 2292 characters, which is consistent with a detailed voting results announcement rather than a brief report publication announcement or a full report.
2023-12-25 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.